Europe

Europe’s Preventable RSV Winter
New ECDC modelling suggests that protecting newborns against RSV could prevent a substantial share of infant hospitalisations during the first months of life. Under a scenario reaching 90% of newborns with long-acting monoclonal antibodies, 61% of RSV hospitalisations in the first two months could be prevented. Europe has the preventive tools. The challenge is making…

Cardiometabolic care tracks glucose and blood pressure

ALS Immune Signals Depend on Where You Look

Europe Has Plans. Implementation Is Lagging

A Second Step for Alzheimer’s Blood Tests

Low testosterone in young men may be a metabolic warning sign, not a treatment target

Severe preeclampsia may leave a measurable signature in the fetal heart

Europe is building the infrastructure to decide which cardiovascular AI can be trusted

Skin Cancer AI Has Crossed a Line: It Is Discharging Patients on Its Own

Alzheimer’s Blood Tests Are Changing Decisions, Not Just Diagnoses
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
